Please login or register first to view this content.
Kidney Disease Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
FDA: Prolia Use in Dialysis Patients May Cause Severe Hypocalcemia
Cognitive Scores Lower for Children With Iron Deficiency
RAAS Inhibitor Discontinuation After Hyperkalemia Tied to Adverse Outcomes
FDA Panel Votes on Tenapanor for Hyperphosphatemia in CKD
Kidney Function Declines More Slowly With SGLT2 Inhibitor
Intravenous vs Oral Iron Does Not Increase CKD Risk
Methotrexate Added to Pegloticase for Gout Safe for Kidneys
Empagliflozin Cuts Risk of Kidney Disease Progression, CV Death in CKD Patients
AKI, CKD Progression Less Likely With Direct Oral Anticoagulants
Benefit of Ticagrelor-Aspirin in Stroke Patients Tied to Renal Function
Budesonide Improves Kidney Parameters in IgA Nephropathy
FDA Panel Votes on Daprodustat for Anemia of Chronic Kidney Disease
FDA Needs Additional Time to Review Sparsentan, Tofersen Applications
Reports of Vial Breakage Prompt Recall of Sodium Bicarbonate Injection
September 2022: Notable Drug Approvals
Oxlumo Indication Expanded to Include Patients With Advanced PH1
Bevacizumab Biosimilar Alymsys Now Available
FDA Extends In-Use Period for Jelmyto Following Reconstitution
